Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Ortiz de Lejarazu R
  • Pumarola T
  • Martin-Loeches I
  • Varillas D
  • Gallegos MC
  • Serón C
  • Micheloud D
  • Gomez JM
  • Tenorio-Abreu A
  • Ramos MJ
  • Molina ML
  • Huidobro S
  • Sanchez E
  • Villanueva B
  • López CJ
  • Rodríguez-Domínguez M
  • Galan JC
  • Lietor A
  • Rojo S
  • Eiros JM
  • Hinojosa C
  • Gonzalez I
  • Torner N
  • Banner D
  • Leon A
  • Cuesta P
  • Rowe T
  • Kelvin DJ

Grupos

Abstract

Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences in early immune response in both mild and severe patients infected with nvH1N1.

Datos de la publicación

ISSN/ISSNe:
1364-8535, 1466-609X

CRITICAL CARE  BMC

Tipo:
Article
Páginas:
-
PubMed:
20003352
Factor de Impacto:
1,829 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 307

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Cita

Compartir